Side effects of Estelle-35 ED in details
Like all medicines, Estelle-35 ED can cause adverse effects although not everybody gets them. Estelle-35 ED is generally well tolerated.
If any of the adverse effects get serious, or if the patient notices any adverse effects not listed, please tell the doctor or pharmacist.
Serious reactions associated with the use of Estelle-35 ED, as well as the related symptoms are described in Precautions.
The following adverse effects have been reported by users of Estelle-35 ED, although they need not to be caused by Estelle-35 ED. These adverse effects may occur in the first few months that the patient is using Estelle-35 ED and usually lessen with time.
If the patient suffers from hereditary angioedema, exogenous estrogen can trigger or exacerbate symptoms of angioedema.
Estelle-35 ED contraindications
If the patient is allergic (hypersensitive) to Ethinylestradiol (Estelle-35 ED), Cyproterone (Estelle-35 ED) acetate or any ingredients of Estelle-35 ED.
Patients has or has ever had disorder affecting blood circulation, in particular, those conditions relating to thrombosis: Formation of a blood clot in the blood vessels of the legs (deep vein thrombosis), the lungs (pulmonary embolism), the heart (heart attack) or other parts of the body; stroke (caused by a blood clot or a rupture of a blood vessel in the brain); condition that may be a 1st sign of a heart attack (eg, angina pectoris or chest pain) or stroke (eg, transient ischemic attack or small reversible stroke), history of migraine accompanied by visual symptoms, speech disability, or weakness or numbness in any part of the body; diabetes mellitus with blood vessel damage; pancreatitis (an inflammation of pancreas) associated with high levels of fatty substances in the blood; jaundice (yellowing of the skin) or severe liver disease; cancer that may grow under the influence of sex hormones (eg, of the breast or genital organs); benign malignant liver tumor; unexplained vaginal bleeding.
If any of these conditions appear for the 1st time while using Estelle-35 ED, stop taking it at once and consult the doctor. In the meantime, use non-antiandrogen therapy measures.
Estelle-35 ED is not to be used by males.
Use in Pregnancy: Estelle-35 ED must not be used by women who are pregnant or who think they might be pregnant. If the patient suspects that she is pregnant while using Estelle-35 ED, the patient should consult the doctor as soon as possible.
Use in Lactation: Estelle-35 ED must not be used during breastfeeding.
References
- DTP/NCI. "CYPROTERONE ACETATE: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
- European Chemicals Agency - ECHA. "6-chloro-1-β,2-β-dihydro-17-hydroxy-3'H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione 17-acetate: The information provided here is aggregated from the "Notified classification and labelling" from ECHA's C&L Inventory. ". https://echa.europa.eu/information-o... (accessed September 17, 2018).
- HSDB. "CYPROTERONE ACETATE". https://toxnet.nlm.nih.gov/cgi-bin/s... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Estelle-35 ED are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Estelle-35 ED. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported side effects
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
